# Scrub Capital

> Scrub Capital is a VC fund backing Health Care and Software. See 10 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 10
- Last investment: Mar 2026
- Lead investor: 10%
- Last updated: Aug 2026

Scrub Capital is an investment firm.

## Contacts

5 contacts available for Scrub Capital. Shizune tracks 1 team members at Scrub Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/scrub-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 70% |
| Software | 2 | 20% |
| Medical Device | 2 | 20% |
| Medical | 1 | 10% |
| Wellness | 1 | 10% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 40% |
| Seed | 3 | 30% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ron Vianu | Limited Partner | 1 | https://shizune.co/investors/profile/ron-vianu |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AvoMD | AvoMD is a no-code software platform that transforms clinical content – guidelines, algorithms, pathways, and checklists - into "virtual clinical consults" available instantly at the point-of-care on standalone web/mobile apps and in the EHR. Leading societies and health systems partner with AvoMD to transform authoritative clinicalexpertise into instant expert guidance at the bedside. Studies show that AvoMD improves outcomes while saving clinicians ~50% of their time in accessing and using information at the point-of-care. | $10M | Series A | Mar 31, 2026 |  |
| Clarity Pediatrics | Clarity Pediatrics is reimagining pediatric chronic care, starting with ADHD. Nearly 10% of American children are diagnosed with ADHD, and for parents it can feel impossible to get the right care. We are building a virtual pediatric ADHD clinic that delivers trusted care to all families. Our new clinical model is tech-enabled, backed by the bestscience, and has the potential to deliver exceptional health outcomes to transform a child’s trajectory. | $14.5M | Series A | Dec 17, 2025 |  |
| Radial | Radial provides new medical treatments for mental conditions including treatments like neuromodulation and rapid acting medications. | $50M | Series A | Dec 09, 2025 |  |
| Spark Spine | Spark Spine is a medical device company that develops next-generation technologies for healing spinal and orthopedic trauma. Spark Spine is a medical device startup developing regenerative technologies for spinal and orthopedic healing. Its proprietary piezoelectric biomaterial, EMP, is engineered to activate endogenous repair pathways and restorefunctional tissue faster and more effectively than conventional implants. |  | Seed | Oct 02, 2025 |  |
| Elion | Elion is an independent and authoritative digital health software marketplace. Elion is the trusted source for healthcare builders to discover, evaluate, and select the software they need to run their businesses. The company's mission is to improve healthcare delivery by enabling startups and incumbents alike to make better, faster technologydecisions. | $9.3M | Seed | Aug 06, 2025 |  |
| Elion | Elion is an independent and authoritative digital health software marketplace. Elion is the trusted source for healthcare builders to discover, evaluate, and select the software they need to run their businesses. The company's mission is to improve healthcare delivery by enabling startups and incumbents alike to make better, faster technologydecisions. | $9.3M | Seed | Aug 06, 2025 |  |
| Elion | Elion is an independent and authoritative digital health software marketplace. Elion is the trusted source for healthcare builders to discover, evaluate, and select the software they need to run their businesses. The company's mission is to improve healthcare delivery by enabling startups and incumbents alike to make better, faster technologydecisions. | $9.3M | Seed | Aug 06, 2025 |  |
| SuperDial | SuperDial leverages conversational AI to automate tedious outbound phone calls on behalf of healthcare organizations. Our customers include leading RCM companies, DSOs, digital health providers, and provider data vendors. We help these customers automate a variety of call types including benefits verifications, claim follow-ups, prior authfollow-ups, credentialing & enrollment follow-ups and provider data inquiries. SuperDial can be extended to new use cases, so if there's another type of outbound phone call you'd like to automate, please reach out to us! | $12M | Series A | Jun 24, 2025 |  |
| Posterity Health | Posterity Health educate, engage, and encourage couples to approach the conception process together as an integrated unit. Posterity Health is the only digital male fertility platform that empowers men to learn about their partner's fertility and take action. | $17M | Series A | Feb 18, 2025 |  |
| Photon | A modern prescription network | $9M | Seed | Aug 15, 2024 |  |

10 of 10 investments shown.

## Co-investors
- [Max Ventures](https://shizune.co/investors/profile/basset-investment-group) — VC Fund, 6 deals together
- [Cedars-Sinai Health Ventures](https://shizune.co/investors/profile/cedars-sinai-health-ventures) — VC Fund, 6 deals together
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund, 6 deals together
- [TMV](https://shizune.co/investors/profile/trail-mix-ventures) — VC Fund, 6 deals together
- [AlleyCorp](https://shizune.co/investors/profile/alleycorp) — VC Fund, 4 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 4 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Scrub Capital invest in?

Scrub Capital invests primarily in Health Care, Software and Medical Device startups, most often at Series A and Seed stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Scrub Capital?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Scrub Capital?

The team at Scrub Capital includes Ron Vianu (Limited Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co